Syngene International Ltd News

Biocon arm Syngene eyes late-stage clinical supplies amid regulatory shift

As regulators ease biosimilar trial norms, Syngene International is expanding into late-stage clinical supply production, betting on biologics and peptide manufacturing for growth

Updated On : 06 Nov 2025 | 5:15 PM IST

Syngene Q2 profit drops 37% as biologics correction offsets growth

Revenue up 2% YoY to Rs 926 crore as research services offset biologics inventory correction; company maintains FY26 guidance

Updated On : 05 Nov 2025 | 9:45 PM IST

Jefferies upbeat on India CRDMO; initiates Buy on Cohance; upgrades Divi's

Jefferies is optimistic on India's CRDMO sector, given its evolution from quasi-chemical firms into strategic partners for innovators; check more details

Updated On : 25 Aug 2025 | 12:11 PM IST

Syngene Q1 PAT up 59% to ₹87 crore, operational revenue rises 11%

Syngene's Q1 FY26 profit rose to Rs 87 crore as Research Services drove contract conversions, while operational revenue rose 11 per cent to Rs 875 crore

Updated On : 23 Jul 2025 | 6:58 PM IST